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ABSTRACT
Objectives To evaluate the effect of four- phase national 
lockdown from March 25 to May 31 in response to the 
COVID-19 pandemic in India and unmask the state- wise 
variations in terms of multiple public health metrics.
Design Cohort study (daily time series of case counts).
Setting Observational and population based.
Participants Confirmed COVID-19 cases nationally and 
across 20 states that accounted for >99% of the current 
cumulative case counts in India until 31 May 2020.
Exposure Lockdown (non- medical intervention).
Main outcomes and measures We illustrate the masking 
of state- level trends and highlight the variations across 
states by presenting evaluative evidence on some aspects 
of the COVID-19 outbreak: case fatality rates, doubling 
times of cases, effective reproduction numbers and the 
scale of testing.
Results The estimated effective reproduction number 
R for India was 3.36 (95% CI 3.03 to 3.71) on 24 March, 
whereas the average of estimates from 25 May to 31 
May stands at 1.27 (95% CI 1.26 to 1.28). Similarly, the 
estimated doubling time across India was at 3.56 days on 
24 March, and the past 7- day average for the same on 
31 May is 14.37 days. The average daily number of tests 
increased from 1717 (19–25 March) to 113 372 (25–31 
May) while the test positivity rate increased from 2.1% 
to 4.2%, respectively. However, various states exhibit 
substantial departures from these national patterns.
Conclusions Patterns of change over lockdown periods 
indicate the lockdown has been partly effective in 
slowing the spread of the virus nationally. However, there 
exist large state- level variations and identifying these 
variations can help in both understanding the dynamics 
of the pandemic and formulating effective public health 
interventions. Our framework offers a holistic assessment 
of the pandemic across Indian states and union territories 
along with a set of interactive visualisation tools that are 
daily updated at  covind19. org.
INTRODUCTION
COVID-19 is an infectious disease caused by 
SARS- CoV-2.1 First identified in December 
2019 in Wuhan, China, it has since spread 
globally, resulting in an ongoing pandemic.2 
As of 9 June 2020, at the time of writing this 
paper, more than 7 million cases have been 
reported across 188 countries and territo-
ries, resulting in more than 405 000 deaths. 
India, a democracy of 1.35 billion with a high 
population density and fragile healthcare 
infrastructure, is one of the global epicentres 
for this pandemic. The first reported coro-
navirus infection in India was on 30 January 
2020 and was identified as being imported by 
travel. The government of India had initially 
responded to the pandemic with closing 
its borders and suspending all visas. With 
the pandemic accelerating throughout the 
world, the government began issuing advi-
sories regarding social distancing measures 
and eventually, India implemented a strict 
nationwide lockdown from 25 March until 
Strengths and limitations of this study
 ► Provides one of the first comprehensive nationwide 
as well as state- level evaluation of the effect of na-
tional lockdown on progression of COVID-19 in India 
using an ensemble of public health metrics.
 ► Provides a set of public health metrics displayed via 
interactive visualisation tools that are daily updated 
at covind19.org to help inform dynamic policy to-
wards containment and mitigation.
 ► Introduces the concept of a cascade of ‘peaks’ 
across states instead of a solitary and unique na-
tional peak for the daily virus incidence curve.
 ► Metrics presented in this study do not include pre-
dictions of future daily active cases nor account for 
age- sex structure and mobility patterns and thus do 
not inform us about projected healthcare needs.
 ► Does not assess the degree of under- reporting in 
cases and deaths and does not consider broader 
and long- term impacts of the lockdown, for exam-
ple, the economic and social costs.
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31 May 2020,3 after which phased lockdown for contain-
ment zones is in effect until 30 June 2020.4 The govern-
ment implemented a zonal classification of regions in the 
nation, with each region falling in one of three classes—
red zones (hotspots with high doubling rates and high 
number of active cases), orange zones (non- hotspots with 
fewer cases) and green zones (regions without confirmed 
cases or without new cases in the previous 21 days). In 
addition to nationwide response patterns, Indian state 
governments responded to the pandemic with various 
declarations of emergency, closure of institutions and 
public meeting places, in addition to other restrictions to 
contain the spread of the virus. Table 1 provides an over-
view of said variations over the four phases of lockdown in 
India. As of 11 June, the number of total confirmed cases 
in India has crossed 298 000, of whom 8501 have died and 
146 972 have recovered, placing India at a worldwide rank 
of 4 in terms of total confirmed cases.5 The number of new 
Table 1 National and state- level lockdown measures implemented over the course of COVID-19 pandemic in India
Lockdown phase Nationwide measures implemented State- level variation in measures implemented
Phase 1
(25 March to 14 April)
All transport services—road, air and rail—were 
suspended, with exceptions for transportation 
of essential goods, fire, police and emergency 
services. Educational institutions, industrial 
establishments and hospitality services were also 
suspended.* Services such as food shops, banks 
and ATMs, petrol pumps, other essentials and their 
manufacturing were exempted.†
Gujarat, Himachal Pradesh, Karnataka, 
Maharashtra, Tamil Nadu, Sikkim and Telangana 
sealed state borders. Additionally, Maharashtra, 
Telangana and Tamil Nadu imposed Section 144, 
outlawing large gatherings of people.‡
Phase 2
(15 April to 3 May)
Conditional relaxation promised after 20 April, 
subject to containment of spread. Lockdown areas 
classified into red, orange and green zones based 
on extent of spread of disease. Certain relaxations 
from 20 April: agricultural businesses, including 
dairy, aquaculture and plantations allowed to open. 
Cargo transportation vehicles allowed to operate. 
Banks and government centres distributing 
benefits allowed to open as well.§
In interest of economic recovery, certain states 
like Maharashtra chose to allow specific business 
activities to resume, in addition to national easing 
of restrictions. Karnataka chose to ease the 
lockdown in certain areas, while Delhi, Punjab 




Zonal classification of regions into red, orange and 
green zones continued, with normal movement 
allowed in green zones. Movement of private and 
hired vehicles allowed in orange zones and red 
zones remained in lockdown. Zonal classifications 
revised on a weekly basis.**
Delhi allowed public and private- sector offices to 
reopen, with social distancing measures in place. 
Maharashtra eased most industrial and commercial 
activities. Gujarat and Jharkhand allowed no 
relaxation, while Bihar, Uttar Pradesh, Rajasthan 
and Madhya Pradesh chose to mostly adhere to 
guidelines issued by the Union Home Ministry.††
Phase 4
(18–31 May)
Unlike the previous phases, states were given a 
larger say in the demarcation of green, orange and 
red zones and the implementation roadmap. Red 
zones were further divided into containment and 
buffer zones. Local administrative bodies were 
given the authority to demarcate containment and 
buffer zones.‡‡
Restricted individual movement allowed in Delhi, 
while Maharashtra, Tamil Nadu and Telangana 
extended the lockdown further. Karnataka allowed 
public transport with social distancing measures, 
while West Bengal began easing workplace 
restrictions. Stand- alone shops were allowed to 
open for short durations.§§
*Guidelines on measures to be undertaken by ministries/departments of government of India, state/union territory governments and state/
union territory authorities for containment of COVID-19 epidemic in the country (https://www.mha.gov.in/sites/default/files/Guidelines.pdf).
†The Economic Times: India’s 21- day lockdown to counter coronavirus: what’s exempt, what’s not, 25 March 2020 (https://economictimes.
indiatimes.com/news/politics-and-nation/india-21-day-lockdown-what-is-exempted-what-is-not/articleshow/74798725.cms).
‡Wikipedia: https://en.wikipedia.org/wiki/Indian_state_government_responses_to_the_COVID-19_pandemic.
§BBC: Coronavirus lockdown guidelines: what has India changed under new rules? 15 April 2020 (https://www.bbc.com/news/world-asia-
india-52290761).
¶Hindustan Times: Complete list of states with no relaxation in lockdown 2.0 restrictions, 20 April 2020 (https://www.hindustantimes.com/
india-news/complete-list-of-states-with-no-covid-19-lockdown-2-0-relaxation/story-pfE5K3Pn5LSZrgFEvC84hO.html).
**India Today: Full list of red, yellow, green zone districts for lockdown 3.0, 1 May 2020 (https://www.indiatoday.in/india/story/red-orange-
green-zones-full-current-update-list-districts-states-india-coronavirus-1673358-2020-05-01).
††Hindustan Times: COVID-19 lockdown 3.0: a look at relaxations, restrictions across major states in India, 4 May 2020 (https://www.
hindustantimes.com/india-news/coronavirus-update-covid-19-lockdown-3-0-a-look-at-relaxations-restrictions-across-major-states-in-india/
story-J5Z2IypwiagUTFf1wYW0jN.html).
‡‡The Economic Times: Lockdown 4.0 guidelines: nationwide lockdown extended until 31 May, with considerable relaxations, 21 May 2020 
(https://economictimes.indiatimes.com/news/politics-and-nation/centre-extends-nationwide-lockdown-till-may-31-with-considerable-
relaxations/articleshow/75790821.cms).
§§BBC: India lockdown 4.0: what is allowed in your city? 19 May 2020 (https://www.bbc.com/news/world-asia-india-52707371).
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cases in India is not on the decline even after 9 weeks of 
national lockdown. There is state- level variability in terms 
of non- medical interventions and with respect to testing 
patterns (both in terms of testing strategies as well as test 
kits being used). The tests primarily used are the rapid 
antigen tests and reverse transcription PCR (RT- PCR) 
tests, with the former being given priority in containment 
zones and points of entry, while the latter are more widely 
used in non- containment areas and hospital settings.6
In light of tremendous public health interest, 
numerous data repositories, along with statistical models, 
are being developed with the aim of studying the effect 
of COVID-19 non- medical interventions. The focus of 
modelling is shifting from forecasting to evaluation of the 
effect of various interventions on the spread of the virus.7 
As of 9 June, 4880 COVID-19 SARS- CoV-2 preprints have 
been uploaded to medRxiv and bioRxiv, of which at least 
30 focus on analysing the efficacy of the non- medical 
interventions implemented by the Indian government. 
Ray and colleagues studied the short- term and long- term 
impacts of the initial lockdown on the total number of 
cases in India using standard epidemiological forecasting 
models, and concluded that the lockdown stood a good 
chance of reducing the total number of cases in India in 
the short term.8 Looking at several metrics, Mitra and 
colleagues suggested that curtailment strategies employed 
by the Indian government seem to have been effective in 
controlling the spread of the pandemic in the country.9 
Ghosh and colleagues investigated the spread of the virus 
and subsequent impact of preventive measures on the 
same at a state level in India and noted that the lockdown 
has had differential effects on daily infection rates for 
various states in India.10 Jakhar and colleagues modelled 
data released by the Indian Ministry of Health and Family 
Welfare using the classical susceptible- infected- recovered 
(SIR) model and calculated the basic reproduction 
number (R0) for India as a whole, along with state- specific 
values of the same.11 Similarly, Gupta estimated key epide-
miological parameters and evaluated the effect of control 
measures on the COVID-19 epidemic in India and its 
states using a dynamic compartment- based susceptible- 
exposed- infected- removed (SEIR) modelling approach, 
reiterating that state- specific R0 values exhibit high vari-
ability with respect to the national value of R0.
12 However, 
much is left to be done now that the nationwide lockdown 
has ended and a targeted lockdown phase is ongoing. All 
epidemiological projections suggest that current gains 
may be reversed rapidly if air travel and social mixing 
resume. For the time being, the general guideline is to 
reopen the country in a phased manner.13 The need of 
the hour is to study and analyse infection, recovery and 
fatality trends at a more granular level using multiple 
measures of assessing epidemic dynamics to ensure the 
formulation of targeted and customised interventions 
aimed at containment and mitigation.
In this paper, we consider an ensemble of metrics including 
case and death counts, case fatality rates (CFR), effective basic 
reproduction numbers, doubling times (DT) and assessment 
Figure 1 Daily number of reported cases, fatalities and recovered cases in India (panel A) over the period between 15 March 
and 31 May with four states to capture the variation. Kerala (panel B) was doing well initially but has seen a recent surge of 
cases. Punjab (panel C) is an example state of ‘doing well’ whereas case counts in Maharashtra (panel D) and Delhi (panel E) are 
still increasing.
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of testing across states for a deeper and policy- relevant 
understanding of the COVID-19 situation in India after four 
contiguous periods of lockdown from 25 March to 31 May 
(lockdown 1.0: 25 March to 14 April,14 lockdown 2.0: 15 April 
to 3 May,15 lockdown 3.0: 4 May to 17 May,16 lockdown 4.0: 
18 May to 31 May17). By studying the series of natural experi-
ments across the states and learning from their successes and 
failures, one has a better likelihood of designing improved 
targeted interventions for the next phase of the pandemic. 
Our proposed comprehensive dashboard has broader utility 
for policymakers and the supporting interactive platform 
presents daily updates for all metrics and models.
METHODS
We use publicly available data for all our analyses ( covid-
19india. org and Our World In Data).5 18 All source code 
and interactive plots are available at  covind19. org.19 All 
computations were done using the RStudio platform.
Case and death counts and fatality rates
In addition to simple case and death counts, we look at CFRs 
estimated using all confirmed cases (CFR1, ratio of the total 
number of deaths and the total number of cases) and closed 
cases only (CFR2, ratio of the total number of deaths and 
the sum of the same and the total number of recovered 
cases). We construct appropriate CIs for these measures.20
DTs and growth rates/reproduction number
To quantify the growth of the pandemic, we estimated DTs 
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COVID-19 in India Dashboard
© COV-IND-19 Study Group
Source: covid19india.org (data through May 31)
Figure 2 Forest plot dashboard. (A) Forest plot of estimated case fatality rates (CFR1) based on all confirmed cases as of 
31 May, along with 95% CIs, for 20 states and union territories of India, and a national summary.(B) Forest plot of estimated 
doubling times (in days) based on data from a 7- day past window from 31 May, along with 95% CIs, for 20 states and union 
territories of India, and a national summary. (C) Forest plot of estimated time- varying R (effective basic reproduction number) 
based on data from a 7- day past window from 31 May, along with 95% CIs, for 20 states and union territories of India, and a 
national summary. (D) Forest plot of test positivity rates (proportion scale) based on data as of 31 May, for 20 states and union 
territories of India, along with a national summary.
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window. This measure gives the number of days it would 
take for total cases to double if its trajectory remained 
as observed in the past week, and an increase in the 
DT is evidence of the pandemic slowing down. We use 
a descriptive measure as well as fit a log- linear model to 
estimate the DT (see online supplemental material). We 
also use a Bayesian sequential method to estimate the 
time- varying effective basic reproduction number, R, which 
measures the average number of persons infected by an 
infected individual. When R falls below 1, the epidemic 
starts slowing down.21 The estimation of the time- varying 
R is performed using the EpiEstim package in R and daily 
case count data from COVID-19 India.5 21 In particular, we 
used the vectors of daily new cases as our input using the 
‘parametric_SI’ estimation method and a 5- day window 
(‘estimate_R’ function, which was used to describe the 
progression of the outbreak in Wuhan).22 We also use a 
gamma distribution prior with a mean of 7 days and an 
SD of 4.5 days, based on research by Wu and colleagues, 
for the generation time (a distribution of the onset of 
disease used to estimate R).23
Testing summaries
In order to understand the testing landscape, we compute 
the proportion of population tested, test positivity rates 
(TPRs) and quantify testing metrics (number of tests, TPR, 
percentage of population tested) at the national and state 
levels. We also introduce a metric of testing shortfall which 
can be used after lockdown during the state of control of a 
pandemic to ensure sustained control of the TPR at a target 
level (eg, in May WHO recommended this target to be set at 
5%24). This may be useful for India after the daily incidence 
curve turns the corner which unfortunately did not happen 
during our study period of lockdown.
Figure 3 National estimates of doubling times and time- varying R. (A) Estimated doubling times of total number of COVID-19 
cases in India, with averages for the prelockdown and postlockdown periods and past 7- day average as of 31 May. (B) 
Estimated time- varying R (effective basic reproduction number) for COVID-19 in India with averages for the prelockdown and 
postlockdown periods and past 7- day average as of 31 May, along with 95% CIs.
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The detailed definition of each reported metric and 
methods for computing corresponding measures of 
uncertainty are presented in the online supplemental 
methods. All our analyses use data available from 15 
March until 31 March, 31 March being the day India’s 
strict national lockdowns ended and ‘unlocking’ started.
Patient and public involvement
No patient involvement.
RESULTS
Total number of cases and deaths
India had reported its first case of COVID-19 on 30 January. 
The first death from COVID-19 was reported on 12 March. 
In the second week of May, India recorded the highest 
growth in case counts among Asian countries.19 As of 9 
June, only four countries (USA, Brazil, Russia and UK) had 
recorded more cases than India.25 Online supplemental 
figure 1 presents national trends of the COVID-19 outbreak 
in India by plotting the cumulative number of confirmed 
cases, fatalities and recovered cases. To highlight the 
pronounced geographic pattern across states not visible in 
online supplemental figure 1, figure 1 compares the daily 
profile of the pandemic at the national level with four states: 
two that are doing well (Kerala and Punjab) and two that 
have been hit hard (Maharashtra and Delhi) in terms of the 
same three counts. It is clear that Punjab has been doing 
well and has experienced the first initial peak, Kerala seems 
to have many new cases after the strong initial control, Maha-
rashtra has an increasing trend that seems to be stabilising 
while Delhi has a high number of cases with a sudden jump 
in case counts near the end of the nationwide lockdown. 
Since Maharashtra contributes nearly 35%–40% of India’s 
total number of cases, the national pattern has more resem-
blance to Maharashtra. Two crucial points emerge from the 
geographic pattern. First, the concentration of the case load 
Figure 4 State- wise estimates of doubling times and time- varying R. (A) Estimated doubling times of total number of 
COVID-19 cases in 20 Indian states and union territories. (B) Estimated time- varying R (effective basic reproduction number) for 
COVID-19 in 20 Indian states and union territories along with 95% CIs.
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among the top 10 states has remained relatively stable, at 
around 90% of the national case count, over this 2- month 
period. Second, the membership of the top 10 states has 
changed gradually—even as Maharashtra, Delhi and Uttar 
Pradesh have continued to figure in the list at all four lock-
down markers. Online supplemental figures 2 and 3 plot 
cumulative case and death counts, respectively, across states 
and over time to highlight these geographic patterns.
Case fatality rates
Figure 2A (CFR1) and online supplemental figure 4 (CFR2) 
present forest plots of the two estimates of the CFR, along 
with 95% CIs, for the 20 states/union territories and for 
the nation as a whole. Using CFR1, there are several states 
with CFR1 above 3%: Gujarat (6.2%), West Bengal (5.8%), 
Madhya Pradesh (4.3%) Maharashtra (3.4%) and Telan-
gana (3.0%). Similarly, the same five states plus Delhi have 
elevated CFR2 estimates (above 6%).
DT and reproduction number
Figure 3A plots the estimated DTs and figure 3B plots the 
estimated time- varying R nationally. Since reliable esti-
mates of DT and R require many days of data, figure 3A,B 
starts on 15 March. In both, we report the estimate (along 
with the 95% CIs for R) on 24 March, 14 April, 3 May and 
18 May corresponding to the initial lockdown and subse-
quent extensions, in order.
The time series patterns of estimated DT and R nationally 
show that the lockdown did slow down the spread of the 
pandemic. It took about 2 weeks for the DT to start moving 
up in a sustained manner. Since early April, the DT has 
increased from about 5 to over 14 days by the end of May 
(figure 3A). Turning to figure 3B, we see that the estimated 
value of R fell over the first lockdown from 3.36 (95% CI 
3.03 to 3.71) on 24 March to 1.71 (95% CI 1.66 to 1.76) on 
14 April, with substantial fluctuation in between. Since then, 
the estimated R has fallen at a slower pace. The trailing 7- day 
average value of R for the week ending on 31 May is 1.27 
(95% CI 1.26 to 1.28).
These national patterns hide substantial state- level 
variations, observable in state level (figure 4A (DT) and 
figure 4B (R)). Figure 4A shows that estimated DTs have 
mostly increased, with Assam, Delhi, Haryana, Odisha 
and Uttarakhand being some noteworthy exceptions. 
Figure 4B indicates that starting from higher values, esti-
mates of R have generally fallen across all states. Again, 
there are significant differences across states—some 
states continue to have high values (eg, Maharashtra), 
and some others, after a period of low estimates of R, have 
reverted to relatively high value (eg, Kerala).
Figure 2B,C presents forest plots of the average value of 
the DT (with 7- day range) and estimated R (with 95% CI) 
over the week before 31 May, respectively. Only two states 
have estimated R below 1 (Madhya Pradesh and Gujarat) 
and four states have estimated R over 2 (Assam, Uttara-
khand, Haryana and Kerala).
Testing coverage and TPR
Going by national- level data, India seems to be doing fairly 
well in terms of TPRs. Since mid- April, India’s TPR has 
fluctuated around 0.04 (figure 5). This is lower than many 
European and North American countries at that time, 
and significantly lower than its neighbours, like Bangla-
desh and Pakistan.8 26 But this national trend hides the 
wide variation across states. Online supplemental figure 
5 plots the TPR over time for our sample of 20 states/
union territories, exhibiting obvious and striking state- 
wide variations (with recent estimates being summarised 
in figure 2D). Rising TPR is noted in most of these states 
where the pandemic is geographically concentrated. 
Important examples are Delhi, Gujarat, Maharashtra 
and Tamil Nadu, which have both high case counts and 
high/rising TPRs. Bihar, Telangana and Uttarakhand, 
with relatively low case counts so far, are witnessing rising 
TPRs, as seen in table 2, which also contains the propor-
tion of population tested by 31 May across each state 
(online supplemental table 1 is an updated version of this 




















as of May 31
COVID-19 test positivity rate in India
©COV-IND-19 Study Group
Source: covid19india.org
Figure 5 Time series plot of test positivity rates for India over the period between 1 April and 31 May.
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Summary state-level dashboard: comprehensive display of 
metrics
With a complete data tsunami, different metrics telling us 
different features of the pandemic and a rapidly evolving 
landscape, we offer a summary dashboard (figure 2) for 
the states and the nation according to various metrics. 
This captures a snapshot of where things stand across 
states and the nation, with daily updates available in our 
app hosted at  covind19. org.19
Figure 2A shows CFR1 along with the 95% CI. While 
the all- India CFR1 on 31 May was 2.84%, state- level CFR1s 
ranged from 6.2% (Gujarat) to 0.2% (Assam). Figure 2B 
shows the 7- day average DT along with the range. The 
quickest DT is in Assam (3.5 days, range: 3.1, 4.0) while 
the slowest DT is in Punjab (73.5 days, range: 51.6, 97.5). 
The national estimate is 14.4 days (range: 13.2, 15.2), 
with about half of states having DT exceeding 14 days.
Figure 2C shows the 7- day average R along with the 
95% CIs. We see that 7- day average estimates range 
from 0.93 (95% CI 0.89 to 0.97) in Gujarat to 3.17 (95% 
CI 2.91 to 3.45) in Assam, with a national estimate of 
1.27 (95% CI 1.26 to 1.28). Figure 2B,C exhibits how 
the DT, a function of cumulative cases, is less sensitive 
to daily movements than R. For example, Kerala has 
done well controlling the outbreak in terms of DT, but 
a small recent increase in observed cases results in a 
7- day average R estimate close to 2.
Figure 2D shows the 7- day average TPR along with the 
range. The lowest 7- day average TPR is seen in Andhra 
Pradesh (0.83%, range: 0.81%, 0.85%), with the highest 
being seen in Maharashtra (13.63%, range: 13.25%, 
14.07%). Generally, states with larger cumulative case 
counts are seen to have higher TPRs. A high TPR most 
likely indicates inadequate levels of testing relative to 
the size of the outbreak. Thus, states with large number 
of reported cases are also likely to be suffering from 
low testing relative to the size of the outbreak in these 
states. The national 7- day average TPR is 4.15% (range: 
4.03%, 4.26%).
It is important to consider these metrics together, 
keeping their nuances in mind:
 ► CFR1 is an indicator of the fatality associated with the 
epidemic, but its value is sensitive to the number of 
tests being performed. A high CFR1 might very well 
arise from inadequate testing. Hence, the CFR1 is best 
used in conjunction with some measure of adequate 
testing.
 ► R can indicate a recent outbreak but is sensitive to the 
level of daily cases being observed (ie, a state/union 
territory with few cases can have a high R). In parallel, 
Table 2 COVID-19 metrics table for India and the 20 states with the most cumulative case counts as of 31 May 2020
Location
Metrics
Total tested Population PPT (%)R Doubling time (days) CFR Test positivity rate
National estimate 1.27 14.4 0.028 0.042 3 737 027 1 332 830 000 0.28
Maharashtra 1.18 13.8 0.034 0.136 463 177 122 153 000 0.38
Delhi 1.46 14.2 0.024 0.086 212 784 19 814 000 1.07
Gujarat 0.93 25.6 0.062 0.079 211 930 67 936 000 0.31
Tamil Nadu 1.19 14.6 0.008 0.044 491 962 75 695 000 0.65
Madhya Pradesh 0.99 21.5 0.043 0.049 167 808 82 232 000 0.2
Bihar 1.19 9.9 0.006 0.044 75 737 119 520 000 0.06
Uttar Pradesh 1.12 17.4 0.027 0.028 289 892 224 979 000 0.13
West Bengal 1.56 14.2 0.058 0.026 203 751 96 906 000 0.21
Rajasthan 1.11 19.1 0.022 0.022 409 777 77 264 000 0.53
Punjab 1.07 73.5 0.020 0.029 87 852 29 859 000 0.29
Uttarakhand 3.14 3.9 0.006 0.021 30 438 11 141 000 0.27
Andhra Pradesh 1.54 23.3 0.017 0.008 372 748 52 221 000 0.71
Assam 3.18 3.5 0.002 0.009 109 097 34 293 000 0.32
Haryana 2.23 12.8 0.010 0.015 118 138 28 672 000 0.41
Jharkhand 1.59 10.1 0.008 0.008 65 886 37 403 000 0.18
Jammu and Kashmir 1.58 14.5 0.011 0.013 171 045 13 203 000 1.3
Karnataka 1.43 10.4 0.016 0.010 293 575 65 798 000 0.45
Kerala 2.04 11.8 0.008 0.015 77 508 35 125 000 0.22
Odisha 1.09 12.0 0.005 0.012 152 131 43 671 000 0.35
Telangana 1.85 18.2 0.030 NA NA 37 220 000 NA
CFR, case fatality rate; NA, not applicable; PPT, proportion of population tested.
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DT is a longer term measure since it is a function of 
cumulative cases (ie, this metric is more robust to 
fluctuations in recent daily cases). These are relative 
metrics and do not inform us about projected health-
care needs.
 ► TPR is both a function of the size of the outbreak in 
an area and the number of tests being performed. A 
higher TPR can indicate insufficient levels of testing 
and selective testing of symptomatic patients but also 
a good predictor of an emerging outbreak when large 
numbers of tests are done.
DISCUSSION
While it is common for analysts and policymakers to 
predict a peak for the COVID-19 in India,27 28 our anal-
ysis shows that the concept of a peak for the whole 
country is, at best, ambiguous. Differences in estimates 
of R (figure 4B) and estimated DTs (figure 4A) suggest 
that peaks will vary across states. Predictions from the 
extended SIR (eSIR)8 29 model available at  covind19. org 
show that peak in case counts might start as early as the 
end of July in some states and go all the way to October 
in many others. (For a description of the method and the 
parameter settings used for the prediction models, please 
refer to the online supplemental methods and accompa-
nying online supplemental figures 6 and 7.) Some states 
like Punjab have already experienced their first peak. 
These predictions are in line with basic intuition about 
the dynamics of the pandemic in India. Initial cases were 
imported, and the initial growth was limited to a few states 
which saw the arrival of international travellers. These 
initial cases seeded the epidemic and saw the explosion 
of cases. With the non- medical intervention of lockdown, 
mobility was limited at the macro level (interstate, inter-
city), which reduced transmission rates (figures 3 and 4). 
Prelockdown infections and micromobility resulted in 
growth of cases within states; notably, the top 10 states on 
18 April and 31 May are largely the same. Now that we are 
in the targeted lockdown phase, internal migration will 
start playing an increasingly important role in the spread 
of the pandemic.
India has a large migrant worker population. Estimates 
of out- of- state and out- of- district migrants ranged from 
60 to 80 million in 2011, and average work- related migra-
tion flows between states over the period 2011–2016 were 
about 9 million per year.30 With the easing of lockdown 
and work slowly resuming, a large migrant population will 
soon start travelling back to their workplaces and India 
could see the next surge in cases in states home to higher 
numbers of migrant workers. At the time of writing this 
paper in June this was our prediction. Indeed, at the time 
of revising the paper, we created pie charts in online 
supplemental figure 8 which show the shift in contribu-
tions of cases by state over time (through 15 September) 
which support our previous conjecture. Additional 
references on COVID-19 models incorporating migra-
tion and mobility can be found in online supplemental 
table 2.31–35 A combined and rigorous strategy of testing 
suspected patients, tracing contacts of patients and 
isolating infected persons can effectively break the chain 
of transmission and slow down the pandemic. Intensi-
fying government messages on social distancing, mask 
wearing, avoiding large indoor gatherings and hygiene 
can allow the country to reopen safely. In a country like 
India, which can ill afford the severe economic disruption 
caused by a lockdown, this alternative approach has much 
to recommend itself.36
Regarding testing, the most common approach is to 
track the TPR, that is, fraction of positives in the total 
number of persons tested.37 High and/or rising TPRs 
indicate that either community prevalence is truly rising 
or that the level of testing is inadequate relative to the 
size of the outbreak so only symptomatic cases are being 
tested. Steady decline in TPR to 5% or less for at least 14 
consecutive days may indicate the pandemic is in a control 
phase,24 that is, an indication that effective R is declining 
and less than 1. The testing shortfall metric can then be 
gainfully employed to determine the number of tests that 
need to be done randomly in the community for surveil-
lance during a control phase. In order to devise a testing 
strategy, it is important not just to think about the number 
of tests but consider various types of tests, including rapid 
antigen test, RT- PCR test and cost- efficient testing strate-
gies such as pooled testing, stratified periodic sampling to 
capture asymptomatic individuals. The goal of testing be it 
for clinical diagnostic purpose, screening or surveillance 
should be clear. The testing shortfall metric may indicate 
that we need to carry out a large number of tests that we 
do not have resources for, but this number can inform us 
when and where to scale up syndromic surveillance using 
community and government healthcare workers.
The estimated prevalence of the disease by TPR will 
usually be an overestimate of the ‘true’ prevalence rate 
due to testing of the symptomatic individuals who are 
more likely to have an active infection. On the other 
hand, under- reporting of silent or covert infections and 
lack of testing of mildly symptomatic individuals is a major 
challenge in estimating the true prevalence and infec-
tion fatality rate (IFR). The extent of under- reporting in 
terms of the number of confirmed cases and deaths is a 
pertinent metric in this context, and the under- reporting 
factor possibly varies across the states. Although we did 
not attempt to estimate the under- reporting factor in 
this paper, largely because our predictions come from an 
eSIR model that does not naturally model the asymptom-
atic infections and hence does not provide estimates of 
the true unreported number of cases, there exist modi-
fications of such model- based approaches providing an 
estimate of the covert infections. An SEIR model applied 
to data from Wuhan, China, has earlier provided esti-
mates of the under- reporting factor in terms of cases and 
deaths.38 In one of our recent works, we extended this 
SEIR model to account for misclassifications due to imper-
fect diagnostic testing and computed revised estimates 
of the under- reporting factor for cases and deaths using 
data from Delhi, the national capital region of India.39 
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We also performed validation for these model- based esti-
mates using estimated seroprevalence information from 
a serosurvey performed in the region.40 Another recent 
study has used a multicountry- modified SEIR model to 
estimate COVID-19 under- reporting across 86 countries 
and has reported significant variability between the coun-
tries in terms of the estimated under- reporting factor.41 
The effect of under- reporting of cases and deaths on IFRs 
can be found in online supplemental table 3. Depending 
on the degree of under- reporting for cases and deaths, 
the IFR ranges from 0.1% to 1.0%. One has to remember 
that even with a low IFR of around 0.1%, if 50% of people 
in India get infected, the nation will incur 670 000 deaths.
Given the spatial and temporal pattern of the pandem-
ic’s spread, it is extremely important to prioritise policies. 
Resources must be mobilised to help one cluster of states 
and then move to the next cluster. It might be useful for 
the central government and the Indian Council of Medical 
Research to classify states in terms of the phases of the 
epidemic. Even as the worst- hit states are being addressed, 
the next set could be put on high alert. It is this dynamic 
policy intervention that will be required to deal effectively 
with the cascading pattern of the pandemic across Indian 
states (refer to table 2 to see state- level variation).
In implementing such a dynamic policy, it is extremely 
important to facilitate replication of successful strategies 
across states. Kerala’s rapid response in terms of testing, 
contact tracing and quarantining; Odisha and Kerala’s 
use of local governance structures and community health 
networks for surveillance and dissemination of correct 
information; Punjab’s use of data analytics and district- 
level granular contact tracing, tracking and isolation—all 
these experiences will be of use in other states that are 
likely to see a surge in cases in the coming weeks.
There are several strengths of this work. First, it provides 
a comprehensive nationwide as well as state- level evalu-
ation of the effect of India’s national lockdown (Ghosh 
et al10 is another notable state- level analysis but focuses 
on forecasting rather than retrospective evaluation) 
on COVID-19 outbreak in India using an ensemble of 
metrics. These metrics can aid policymakers to track and 
assess the spread of the outbreak and identify areas where 
interventions may play an important mitigating role. 
Second, these metrics are publicly available and displayed 
via interactive visualisation tools that are daily updated 
at  covind19. org19 to help inform dynamic policymaking 
and intervention towards containment and mitigation. 
Third, our state- level analysis highlights heterogeneity of 
outbreak progression across India and the concept of a 
cascade of ‘peaks’ across states instead of a solitary and 
unique national peak for the daily virus incidence curve.
There are also some limitations to this work. First, 
the metrics presented do not include predictions of 
future daily active cases and thus do not inform us 
about projected healthcare needs. We also refrain 
from predicting fatalities. The nature of this paper 
is more of retrospective evaluation than prospective 
forecasting. Second, our methods do not account for 
age- sex structure and mobility patterns in India. A full 
spatiotemporal model with more granular data is in 
order. Third, the quality of the data is in question with 
the existence of evidence that reported case counts 
are significantly lower than true case counts. However, 
this data set is the most comprehensive and regularly 
updated data set on COVID-19 in India and the under-
count is likely missing asymptomatic cases rather than 
symptomatic cases. Attempting to correct for misclas-
sification and other data errors is beyond the scope of 
this paper. Finally, we consider a narrow evaluation of 
the lockdown in terms of COVID-19- related outcomes 
using data up to 31 May. There are many long- term 
and broader consequences of the lockdown that this 
paper fails to capture.
The success of some states gives us hope that there are 
strategies to beat this insidious virus that have worked 
in a low- resource setting. Resources can be mobilised 
and optimally deployed to address the acute situations 
in high- density population areas like Maharashtra, 
Gujarat and Delhi. In all these efforts, nuanced state- 
level summaries offer their utility to inform national 
policies.
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